Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Association Between Cardiac Magnetic Resonance Imaging Parameters and White Matter Hyperintensities
Cerebrovascular Disease and Interventional Neurology
Cerebrovascular Disease and Interventional Neurology Posters (7:00 AM-5:00 PM)
135

Identify abnormal cardiac chamber size and hemodynamic parameters on cardiac MRI as predictors of advancing cerebral small vessel disease (CSVD) on brain MRI.

CSVD is a common age-related disorder with its accumulation leading to gait disturbances, mood changes and cognitive decline. Abnormal cardiac structure and function has been hypothesized to either be contributing to advancement of CSVD or develop in parallel. Previously, we identified both normal and significantly abnormal left atrial and right ventricular chamber sizes on 2D transthoracic echocardiogram (TTE) were associated advanced CSVD, while moderately abnormal sizes were predictors of the worst CSVD burden. However, TTE has significant limitations including a degree of subjectivity to its findings. This follow up study utilizes cardiac MRI for obtaining cardiac structural and functional parameters due to its increased objectivity. 

This is a retrospective analysis of University of Utah Health patients from January 2014 to December 2019. We included patients who completed both a cardiac and brain MRI within one year of each other. The primary outcome was the burden of CSVD measured by the total small vessel disease (tSVD) score. Multivariate ordinal logistic regression models to the tSVD score were used with individual predictors of cardiac MRI measurements and adjusted for potential confounders.

A total of 333 individuals are included. The mean (SD) age is 61 (15) years with 63% male (n=211). The  tSVD score will be analyzed with structural and functional parameters from cardiac MRI readings adjusted for demographic and other pertinent clincoradiographic data.

Prior research indicates that cardiac morphology is associated with WMH on brain MRI, however the results have been inconsistent. This finding may be possible due to differences in imaging modalities. This study aims to corroborate previous results using cardiac MRI parameters as a predictor for advancing CSVD on brain MRI.

Authors/Disclosures
Kayla Navarro
PRESENTER
Miss Navarro has nothing to disclose.
Gauri Garg Ms. Garg has nothing to disclose.
Zoe Wolcott, MD Ms. Wolcott has nothing to disclose.
Varsha Muddasani, MBBS (Einstein Medical Center) Dr. Muddasani has nothing to disclose.
Cecilia Peterson An immediate family member of Ms. Peterson has received personal compensation for serving as an employee of 100Plus.
Nazanin Sheibani, MD (Tremont) Dr. Sheibani has nothing to disclose.
Ka-Ho Wong (U of U Neurology Clinic) The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
No disclosure on file
Adam De Havenon, MD, FÂé¶¹´«Ã½Ó³»­ (Yale University) Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Eric Goldstein, MD (Brown University Warren Alpert School of Medicine) Dr. Goldstein has nothing to disclose.